Cart
sales@molnova.com
Landipirdine
CAS No. 1000308-25-7
Landipirdine( RO-5025181 | SYN-120 )
Catalog No. M10003 CAS No. 1000308-25-7
A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 660 | Get Quote |
|
| 10MG | 888 | Get Quote |
|
| 25MG | 1377 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLandipirdine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel 5-HT receptor antagonist for the treatment of Parkinson's disease.
-
DescriptionA novel 5-HT receptor antagonist for the treatment of Parkinson's disease.Parkinson's DiseasePhase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsRO-5025181 | SYN-120
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research AreaNeurological Disease
-
IndicationParkinson Disease
Chemical Information
-
CAS Number1000308-25-7
-
Formula Weight362.419
-
Molecular FormulaC18H19FN2O3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(N)NC[C@@H]1CCCC2=C1C=CC(S(=O)(C3=CC=CC(F)=C3)=O)=C2
-
Chemical NameN-(((1R)-6-(3-fluorobenzenesulfonyl)-1,2,3,4-tetrahydronaphthalen-1-yl)methyl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huot P, et al. ACS Chem Neurosci. 2017 May 17;8(5):973-986.
molnova catalog
related products
-
BF-1
BF-1 is a novel selective 5-HT2 receptor antagonist that acts by blocking neurogenic dural plasma protein extravasation induced by mCPP or BW723C86.BF-1 is used in the study of migraine.
-
Setiptiline
A tetracyclic antidepressant (TeCA) that acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist.
-
PF-04995274
PF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.
